Asundi J, Lacap JA, Clark S, Nannini M, Roth L, Polakis P. MAPK pathway inhibition enhances the efficacy of an anti-endothelin B receptor drug conjugate by inducing target expression in melanoma. Mol Cancer Ther. 2014 Jun;13(6):1599–610. doi: 10.1158/1535-7163.mct-13-0446. PMID: 24651527.